PGY-2 IM Resident @CCF_IMCHIEFS | Post-Doctoral Research Fellow @MayoClinicNeph | M.D.’ 23 @Aub_Lebanon | Aspiring Nephrologist-Scientist 🫘
Cleveland, OH
Joined August 2016
- Tweets163
- Following363
- Followers376
- Likes522
Check out our latest @jclinicalinvest publication, featured in ASN In the Loop @ASNKidney!
We describe a novel vasopressin-independent mechanism of water reabsorption with potential implications for improving tolvaptan tolerability in ADPKD. @fouadchebib
jci.org/articles/view/197021
Abed Borghol retweeted
Happy to share our newly published article in Nephrology Dialysis Transplantation. @NDTsocial
doi.org/10.1093/ndt/gfag010
@rahaai @wisit661 @fouadchebib @abedborghol @ZohrehGh7 @SaynaNorouzi
Kidney stones in ADPKD are common yet often overlooked, with rates from 3-59%.
Check out our recent article on kidney stones in ADPKD, with a focus on how metabolic and structural factors impair drainage and complicate management🫘💎.
@fouadchebib
tandfonline.com/doi/full/10.…
Wonderful time this year at ASN #KidneyWk reconnecting with friends and mentors.
See you next year in Denver! 🫘
@CCF_IMCHIEFS
Abed Borghol retweeted
The September issue of Kidney360 is now available online! Topics covered this month include: - Apixiban vs Warfarin use - Cannabis use and Kidney Transplant Access and Outcomes - and more Check out the issue here: kidney.pub/KID-0925 #ASNJASN Cover by Borghol et al.
Abed Borghol retweeted
This #Review in #ASNKidney360 describes the causes, manifestations, and management strategies for abdominal pain in ADPKD, the most common genetic kidney disorder. kidney.pub/KID0907
Abed Borghol retweeted
Exciting results from study led by Dr. @NabeelAslamMD and @FadiG_MD @MayoClinicNeph @MCFNephFellows
@DrLyleBaker @NephMao @Marietherese43 @abedborghol @AhmadGhanem97
Peritoneal dialysis (PD) is not often used for patients with Autosomal dominant polycystic kidney disease (ADPKD). This #ASNKidney360 research demonstrates that PD is safe and effective for patients with ADPKD. Read more: kidney.pub/KID0888
Chronic pain affects 60% of people with ADPKD, impacting quality of life, daily function, and mental well-being.
Our latest article shows why pain happens in ADPKD with a special focus on acute and chronic pain management strategies 💊🧘♂️
➡️journals.lww.com/kidney360/a…
@fouadchebib
Abed Borghol retweeted
Chebib lab 2024-2025! So proud of this dedicated and hard working team! We couldn’t achieve all the transformational projects and discoveries without your unwavering commitment to make a difference! As we celebrated some team members going into their next chapter, we are excited to welcome others in the coming weeks! @MayoClinic
Abed Borghol retweeted
🚀 Advancing PKD care through bold science and innovative care delivery—pushing the boundaries of what’s possible, with patients at the center. From treatment to transformation, we’re committed to progress from care to cure. Let’s move the field forward together!🔬✨
🎥 Watch here: youtu.be/dByNm9uz-qI?si=sQ_y…
#ResearchInnovation #FutureOfScience @MayoClinic @MayoClinicNeph @PKDFoundation @Mayoclinicpress
Abed Borghol retweeted
Proud to share our team’s latest work in @KIReports:
“Characterizing the ADPKD-IFT140 Phenotypic Signature with Deep Learning and Advanced Imaging Biomarkers”
We define the unique clinical and imaging profile of ADPKD-IFT140 and introduce practical + deep learning models for its detection.
Read: kireports.org/article/S2468-…
#ADPKD #NephTwitter #KidneyImaging #AIinMedicine #ChebibLab
Check out our latest article on intracranial aneurysm screening in ADPKD: who, when, and how to screen, with a focus on targeted screening strategies 🧠🫘 @fouadchebib @MayoClinicNeph
Intracranial aneurysm screening and management is an important aspect of caring for individuals with ADPKD. Check our practical approach on who, how and when to screen! Also how to approach when screening is positive @MayoProceedings @MayoClinicNeph @RabihTawkMD @abedborghol
sciencedirect.com/science/ar…
Abed Borghol retweeted
Thank you for sharing our review article
Great work by team @abedborghol @Marietherese43
Renal and Extrarenal Manifestations of ADPKD from another great review by Dr. @fouadchebib and team.
doi.org/10.1080/0886022X.202…
A bit late to the party, but beyond grateful to have matched at @CCF_IMCHIEFS !
Grateful for my incredible mentor @fouadchebib and my alma mater @AUB_Lebanon @AUBMC_Official for shaping this journey.
One step closer to becoming a nephrologist, and a PKD specialist someday 🫘
Abed Borghol retweeted
4 out of 4 of our PKD research postdocs mentees have matched into internal medicine residency! So proud of them! Always pay it forward! #IMG #Match
@FadiG_MD @AhmadGhanem97 @abedborghol
Abed Borghol retweeted
So proud our @MCFNephFellows nephrology fellow Dr. Rangarajan presenting our study on Peritoneal dialysis in ADPKD @FLNephrology meeting 👏👏
Had an amazing time at #KidneyWk 2024 @ASNKidney ! Honored to present our work on the genotype-phenotype relationships in #ADPKD #ChebibLab. Grateful for my mentor @fouadchebib and reconnecting with previous mentors and colleagues @Koubar_Sahar @MayoClinicNeph @MCFNephFellows
Abed Borghol retweeted
Celebrating the graduation of the 11th SHARP cohort! « You are part of a critical institutional effort to build capacity, ..by investing in the training of the best and brightest who will make a difference for the health of the peoples of the MENA region ». President Fadlo Khuri.
